𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A cost-analysis of suspected adverse drug reactions in a hospital emergency ward

✍ Scribed by I. Ayani; C. Aguirre; G. Gutiérrez; A. Madariaga; J. M. Rodríguez-Sasiaín; M. J. Martínez-Bengoechea

Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
79 KB
Volume
8
Category
Article
ISSN
1053-8569

No coin nor oath required. For personal study only.

✦ Synopsis

The main objective of this study was to analyse the minimum direct cost to the Public Health System (PHS) of diagnosing and treating those patients attended to in the emergency ward (EW) for suspected adverse drug reaction (ADR). The cases were collected during March 1995 in the emergency ward of a 900-bed tertiary teaching hospital that covers 900,000 inhabitants. ADR was considered according to the WHO de®nition. The following EW costs were used: EW physician visit 78.5 ecus (1 ecu 156 pesetas), thorax or abdomen radiograph 21.5 ecus, computerized tomography 112.7 ecus, endoscopy 48 ecus, specialist physician visit 62 ecus. Three types of laboratory costs were considered: block of biochemical tests 16 ecus, biochemical tests with blood count 22.5 ecus, and biochemical tests with blood count and coagulation study 41.6 ecus. Pharmacotherapy of the ADR and changes in patient's usual drug therapy due to ADR were estimated. For patients admitted in the hospital, a per day cost of 391 ecus was considered. A mean ADR cost per organ or system aected (cutaneous, metabolic, gastrointestinal, nervous) was computed.

The main conclusion of this study is that ADR, apart from in¯icting damage on the patients, also incur PHS costs. The quantity of 42,732 ecus during the month of March, in a single hospital, can seem small when compared with the cost of some diseases such as AIDS or ischemic heart disease. But remembering that about 40% of all ADR attended to in hospitals is avoidable, a decrease of 40% could produce an annual saving of 205,216 ecus to the hospital, which is twice the annual budget of the Pharmacovigilance Centre of the Basque Country. Pharmacovigilance centres should include cost analysis of ADR among their objectives, to provide health systems managers with enough information to implement those measures that will result in a better utilization of the scarce resources of the Public Health System.

📜 SIMILAR VOLUMES

A 1-Year Study of Drug Prescriptions and
A 1-Year Study of Drug Prescriptions and Adverse Drug Reactions in Psychiatric Hospital Practice
✍ Marco Cosentino; Olivia Leoni; Laura Rispoli; Carlo Pellegrini; Lucio Finavera; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 682 KB

Drug prescribing habits and adverse drug reaction occurrence were investigated in a psychiatric hospital ward for chronic resident patients, and the usefulness of a drug prescription and adverse event (AE) routine monitoring programme in this setting was assessed. A computerized data base was establ

Analysis of hospital costs as a basis fo
Analysis of hospital costs as a basis for pricing services in Mali
✍ Martine Audibert; Jacky Mathonnat; Delphine Pareil; Raymond Kabamba 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB

## Abstract In a move to achieve a better equity in the funding of access to health care, particularly for the poor, a better efficiency of hospital functioning and a better financial balance, the analysis of hospital costs in Mali brings several key elements to improve the pricing of medical servi

No evidence of increased adverse drug re
No evidence of increased adverse drug reactions in cytochrome P450 CYP2D6 poor metabolizers treated with fluoxetine or nortriptyline
✍ Rebecca L. Roberts; Roger T. Mulder; Peter R. Joyce; Suzanne E. Luty; Martin A. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

## Abstract The polymorphic enzyme cytochrome P450 CYP2D6 is involved in the metabolism of many antidepressants, including nortriptyline and fluoxetine. Some 7%–10% Caucasians have inactivating mutations in both alleles of the __CYP2D6__ gene, and are referred to as poor metabolizers (PMs). Several

Correcting for bias when estimating the
Correcting for bias when estimating the cost of hospital-acquired infection: an analysis of lower respiratory tract infections in non-surgical patients
✍ Nicholas Graves; Diana Weinhold; Jennifer A. Roberts 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 1 views

Hospital acquired infections (HAI) are costly but many are avoidable. Evaluating prevention programmes requires data on their costs and benefits. Estimating the actual costs of HAI (a measure of the cost savings due to prevention) is difficult as HAI changes cost by extending patient length of stay,